Sort
10,766 grants matching “checkpoint inhibitor”
Immunologic Approaches to Ovarian Cancer
$2,033,832Paul J Sabbatini · Sloan-Kettering Inst Can Research · P01 · FY2017 · CA
Applying Bioinformatics to Research in Immune, Muscle, and Bone Diseases
$2,033,275Hong-Wei Sun · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIC · FY2025 · AR
Systems Pharmacology of Therapeutic and Adverse Responses to ImmuneCheckpoint and Small Molecule Drugs
$2,032,638Peter Karl Sorger · Harvard Medical School · U54 · FY2021 · CA
SPORE in Breast Cancer
$2,031,380Jennifer A Pietenpol · Vanderbilt University Medical Center · P50 · FY2022 · CA
Head and Neck Cancer SPORE at the University of Wisconsin
$2,028,647Paul M Harari · University Of Wisconsin-Madison · P50 · FY2022 · CA
Strategies for Cancer Immunotherapy Development: Preclinical Studies
$2,028,388Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Molecularly Targeted Radiosensitization of Locally Advanced Cancers
$2,027,150Theodore S Lawrence · University Of Michigan At Ann Arbor · P50 · FY2025 · CA
MAP4K3 regulation of cellular stress response pathways in health and disease
$2,022,582Albert R La Spada · University Of California-Irvine · RF1 · FY2022 · AG
Head and Neck Cancer SPORE at the University of Wisconsin
$2,021,133Paul M Harari · University Of Wisconsin-Madison · P50 · FY2023 · CA
Immunotherapy for Malignant Mesothelioma and Lung Cancer
$2,018,756Raffit Hassan · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Immunologic Approaches to Ovarian Cancer
$2,002,763Paul J Sabbatini · Sloan-Kettering Inst Can Research · P01 · FY2019 · CA
Integration of Actin Dynamics and Adhesion in Cell Migration
$2,001,484Clare Michal Waterman · National Heart, Lung, And Blood Institute · ZIA · FY2018 · HL
CNT-VECTORED DELIVERY OF MRNA FOR HIV-VACCINES
$1,999,997Yang Xu · Luna Innovations, Inc. · N44 · FY2019 · AI
MOONSHOT - TOPIC 372 - DEVELOPMENT AND VALIDATION OF NON-MOUSE REAGENTS TO ENABLE PRECLINICAL DEVELOPMENT OF NOVEL THERAPEUTICS.
$1,999,381Adriann Sax · Vetigenics Llc · N44 · FY2021 · CA
Vulnerabilities in osteosarcoma and breast cancer
$1,995,196Jing Huang · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
The University of Texas MD Anderson Cancer Center SPORE in Ovarian Cancer
$1,993,287Anil K Sood · University Of Tx Md Anderson Can Ctr · P50 · FY2025 · CA
Centers for Cancer Systems Therapeutics (CaST)
$1,991,851Andrea Califano · Columbia University Health Sciences · U54 · FY2016 · CA
Centers for Cancer Systems Therapeutics (CaST)
$1,991,657Andrea Califano · Columbia University Health Sciences · U54 · FY2017 · CA
MD Anderson Cancer Center SPORE in Gastrointestinal Cancer
$1,987,442Scott Kopetz · University Of Tx Md Anderson Can Ctr · P50 · FY2021 · CA
DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs
$1,970,503Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Role of Viral Reservoirs in the Pathogenesis of HIV Disease
$1,963,172Tae-Wook Chun · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Preclinical drug development in pancreatic cancer
$1,962,634Udo Rudloff · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Immunological Analysis of Brain Cancer
$1,962,200Masaki Terabe · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
SPORE In Prostate Cancer
$1,957,034William George Nelson · Johns Hopkins University · P50 · FY2012 · CA
Radiopharmaceutical Imaging and Therapy of Cancer
$1,954,858Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA